Pembrolizumab, Tumor Response, and Survival in Advanced Melanoma

JAMA Author Interviews - A podcast by JAMA Network

Interview with Antoni Ribas, MD, PhD, author of Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma